<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32440978</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19.</ArticleTitle><Pagination><StartPage>1365</StartPage><EndPage>1367</EndPage><MedlinePgn>1365-1367</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04457-8</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0197-1880</Identifier><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Corso Mazzini 18, 28100, Novara, Italy. fabiolademarchi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantello</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Corso Mazzini 18, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrosini</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Serena Ambrosini, Consoft Sistemi, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Corso Mazzini 18, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CANPALS Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Investimenti a favore della crescita e dell'occupazione</GrantID><Agency>Regione Piemonte</Agency><Country>International</Country></Grant><Grant><GrantID>AGING Project for Department of Excellence at the Department of Translational Medicine (DIMET)</GrantID><Agency>Universit&#xe0; degli Studi del Piemonte Orientale</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020811" MajorTopicYN="N">Biomedical Technology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Sarnelli</LastName><ForeName>Maria Francesca</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Serioli</LastName><ForeName>Marcella</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biroli</LastName><ForeName>Giampaolo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riso</LastName><ForeName>Sergio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vercelli</LastName><ForeName>Renato</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massara</LastName><ForeName>Maurilio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garone</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32440978</ArticleId><ArticleId IdType="pmc">PMC7240164</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04457-8</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04457-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guidon AC, Amato AA (2020) COVID-19 and neuromuscular disorders [published online ahead of print, 2020 Apr 13]. Neurology. 10.1212/WNL.0000000000009566</Citation></Reference><Reference><Citation>Klein BC, Busis NA (2020) COVID-19 is catalyzing the adoption of teleneurology. Neurology. 10.1212/WNL.0000000000009494</Citation><ArticleIdList><ArticleId IdType="pubmed">32238505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollander JE, Carr BG (2020) Virtually perfect? Telemedicine for Covid-19. N Engl J Med 382(18):1679&#x2013;1681. 10.1056/NEJMp2003539</Citation><ArticleIdList><ArticleId IdType="pubmed">32160451</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Van Eenennaam R, Kruitwagen ET et al (2020) Telehealth as part of specialized ALS care: feasibility and user experiences with ALS home-monitoring and coaching. Amyotroph Lateral Scler Frontotemporal Degener:1&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pubmed">32003245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, Garry J, Hubbard J, et al. Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. BMC Neurol. 2019;19(1):104. doi: 10.1186/s12883-019-1330-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1330-6</ArticleId><ArticleId IdType="pmc">PMC6540456</ArticleId><ArticleId IdType="pubmed">31142272</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>